Physical Activity and Risk of Major Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review and Meta-Analysis of Observational Studies.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
01 12 2022
Historique:
received: 06 05 2022
accepted: 19 09 2022
entrez: 1 12 2022
pubmed: 2 12 2022
medline: 6 12 2022
Statut: ppublish

Résumé

Physical activity is a cornerstone in diabetes management; however, evidence synthesis on the association between physical activity and long-term diabetes-related complications is scarce. To summarize and evaluate findings on physical activity and diabetes-related complications, we conducted a systematic review and meta-analysis. We searched PubMed, Web of Science, and the Cochrane Library for articles published up to 6 July 2021. We included prospective studies investigating the association between physical activity and incidence of and mortality from diabetes-related complications, i.e., cardiovascular disease (CVD), coronary heart disease, cerebrovascular events, heart failure, major adverse cardiovascular events, and microvascular complications such as retinopathy and nephropathy, in individuals with diabetes. Study characteristics and risk ratios with 95% CIs were extracted. Random-effects meta-analyses were performed, and the certainty of evidence and risk of bias were evaluated with use of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) and Risk Of Bias In Non-randomised Studies - of Interventions (ROBINS-I) tools. Overall, 31 studies were included. There was moderate certainty of evidence that high versus low levels of physical activity were inversely associated with CVD incidence, CVD mortality (summary risk ratio 0.84 [95% CI 0.77, 0.92], n = 7, and 0.62 [0.55, 0.69], n = 11), and microvascular complications (0.76 [0.67, 0.86], n = 8). Dose-response meta-analyses showed that physical activity was associated with lower risk of diabetes-related complications even at lower levels. For other outcomes, similar associations were observed but certainty of evidence was low or very low. Limitations include residual confounding and misclassification of exposure. Physical activity, even below recommended amounts, was associated with reduced incidence of diabetes-related complications.

Sections du résumé

BACKGROUND
Physical activity is a cornerstone in diabetes management; however, evidence synthesis on the association between physical activity and long-term diabetes-related complications is scarce.
PURPOSE
To summarize and evaluate findings on physical activity and diabetes-related complications, we conducted a systematic review and meta-analysis.
DATA SOURCES
We searched PubMed, Web of Science, and the Cochrane Library for articles published up to 6 July 2021.
STUDY SELECTION
We included prospective studies investigating the association between physical activity and incidence of and mortality from diabetes-related complications, i.e., cardiovascular disease (CVD), coronary heart disease, cerebrovascular events, heart failure, major adverse cardiovascular events, and microvascular complications such as retinopathy and nephropathy, in individuals with diabetes.
DATA EXTRACTION
Study characteristics and risk ratios with 95% CIs were extracted. Random-effects meta-analyses were performed, and the certainty of evidence and risk of bias were evaluated with use of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) and Risk Of Bias In Non-randomised Studies - of Interventions (ROBINS-I) tools.
DATA SYNTHESIS
Overall, 31 studies were included. There was moderate certainty of evidence that high versus low levels of physical activity were inversely associated with CVD incidence, CVD mortality (summary risk ratio 0.84 [95% CI 0.77, 0.92], n = 7, and 0.62 [0.55, 0.69], n = 11), and microvascular complications (0.76 [0.67, 0.86], n = 8). Dose-response meta-analyses showed that physical activity was associated with lower risk of diabetes-related complications even at lower levels. For other outcomes, similar associations were observed but certainty of evidence was low or very low.
LIMITATIONS
Limitations include residual confounding and misclassification of exposure.
CONCLUSIONS
Physical activity, even below recommended amounts, was associated with reduced incidence of diabetes-related complications.

Identifiants

pubmed: 36455117
pii: 147970
doi: 10.2337/dc22-0886
pmc: PMC9862380
doi:

Types de publication

Systematic Review Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3101-3111

Informations de copyright

© 2022 by the American Diabetes Association.

Références

Int J Epidemiol. 2012 Dec;41(6):1585-93
pubmed: 22253315
Acta Diabetol. 2020 May;57(5):527-534
pubmed: 31749048
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Diabetes Care. 2012 Jan;35(1):105-12
pubmed: 22124717
BMC Nephrol. 2020 May 8;21(1):169
pubmed: 32384928
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Biosci Rep. 2021 Jan 29;41(1):
pubmed: 33289502
Circulation. 2009 Jan 6;119(1):44-52
pubmed: 19103991
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Med Sci Sports Exerc. 2022 Feb 1;54(2):353-368
pubmed: 35029593
J Clin Epidemiol. 2017 Jul;87:4-13
pubmed: 28529184
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
Diabetes Res Clin Pract. 2020 May;163:108157
pubmed: 32333968
Diabetologia. 2016 Dec;59(12):2527-2545
pubmed: 27747395
PLoS One. 2017 Mar 3;12(3):e0172890
pubmed: 28257419
Diabetes Obes Metab. 2013 Nov;15(11):1008-12
pubmed: 23675676
Comput Methods Programs Biomed. 2010 Apr;98(1):90-3
pubmed: 19959250
Diabetologia. 2020 Mar;63(3):537-548
pubmed: 31792574
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Circulation. 2004 Aug 10;110(6):666-73
pubmed: 15277321
Ophthalmology. 1995 Aug;102(8):1177-82
pubmed: 9097744
Int J Behav Nutr Phys Act. 2020 Aug 26;17(1):109
pubmed: 32843054
Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:77-87
pubmed: 22435943
Curr Nutr Rep. 2014 Dec;3(4):387-391
pubmed: 25729633
J Am Heart Assoc. 2016 Sep 14;5(9):
pubmed: 27628572
Diabetes Res Clin Pract. 2021 Feb;172:108518
pubmed: 33096191
J Clin Epidemiol. 2007 Mar;60(3):309-17
pubmed: 17292026
Acta Diabetol. 2019 Aug;56(8):823-837
pubmed: 30900027
Diabetologia. 2013 Jan;56(1):82-91
pubmed: 23052062
Diabetes Care. 2016 Nov;39(11):2065-2079
pubmed: 27926890
Eur Rev Med Pharmacol Sci. 2014;18(15):2205-14
pubmed: 25070828
Diabetologia. 2010 Sep;53(9):1886-9
pubmed: 20526577
Diabetologia. 2015 May;58(5):929-36
pubmed: 25634228
Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305
pubmed: 26111994
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Diabetologia. 2017 Mar;60(3):574-580
pubmed: 28013340
Arch Intern Med. 2012 Sep 24;172(17):1285-95
pubmed: 22868663
J Am Heart Assoc. 2020 May 18;9(10):e014885
pubmed: 32390492
Am J Epidemiol. 1992 Jun 1;135(11):1301-9
pubmed: 1626547
Eur J Prev Cardiol. 2014 Feb;21(2):244-51
pubmed: 24227183
Diabetologia. 2021 Mar;64(3):571-580
pubmed: 33190165
Sports Med. 2013 Jan;43(1):39-49
pubmed: 23315755
Med Sci Sports Exerc. 2014;46(5):933-9
pubmed: 24968127
J Diabetes Complications. 2015 Nov-Dec;29(8):1228-33
pubmed: 26316423
Br J Sports Med. 2018 Jul;52(14):890-891
pubmed: 29545236
PLoS One. 2021 Jan 14;16(1):e0239214
pubmed: 33444338
Diabetes Care. 2013 Feb;36(2):471-9
pubmed: 23349151
Circulation. 2022 May 31;145(22):1632-1641
pubmed: 35603600
Diabetes Care. 2014 Apr;37(4):1016-23
pubmed: 24652727
Arch Intern Med. 2003 Jun 23;163(12):1440-7
pubmed: 12824093
Diabet Med. 2021 Oct;38(10):e14646
pubmed: 34270827
JAMA Intern Med. 2021 Sep 1;181(9):1196-1205
pubmed: 34279548
Diabetes Metab Res Rev. 2009 Nov;25(8):725-32
pubmed: 19780066
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967
J Am Coll Cardiol. 2018 Jun 26;71(25):2867-2876
pubmed: 29929608
Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):1985-1992
pubmed: 33965297
Am J Epidemiol. 1991 Jun 15;133(12):1220-30
pubmed: 2063830
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
Ann Oncol. 2012 Apr;23(4):843-52
pubmed: 21890910
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921
pubmed: 27595918
Diabetologia. 2013 May;56(5):1021-30
pubmed: 23443242
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880

Auteurs

Marlene Rietz (M)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Research Unit for Exercise Epidemiology (ExE), Department of Sports Science and Clinical Biomechanics, Syddansk Universitet, Odense, Denmark.

Alexander Lehr (A)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Eriselda Mino (E)

Department of Sport Science and Sport, Division Exercise and Health, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Alexander Lang (A)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Edyta Szczerba (E)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
German Center for Diabetes Research (DZD), Partner Düsseldorf, Düsseldorf, Germany.

Tim Schiemann (T)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Christian Herder (C)

German Center for Diabetes Research (DZD), Partner Düsseldorf, Düsseldorf, Germany.
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Nina Saatmann (N)

German Center for Diabetes Research (DZD), Partner Düsseldorf, Düsseldorf, Germany.
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Wolfgang Geidl (W)

Department of Sport Science and Sport, Division Exercise and Health, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Janett Barbaresko (J)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Manuela Neuenschwander (M)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
German Center for Diabetes Research (DZD), Partner Düsseldorf, Düsseldorf, Germany.

Sabrina Schlesinger (S)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
German Center for Diabetes Research (DZD), Partner Düsseldorf, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH